Login to Your Account

Kuros Mulls Options After Baxter Exits Three Programs

By Cormac Sheridan

Wednesday, April 27, 2011
Kuros Biosurgery AG's longstanding relationship with Baxter International Inc. has dwindled to just one development program following a decision by the latter to hand back rights to three programs it had previously licensed: KUR-111, KUR-113 and KUR-115.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription